⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HELP News
Cybin Inc. Common Stock
HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
globenewswire.com
HELP
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
prnewswire.com
HELP
TAK
AZN
JNJ
ABBV
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
globenewswire.com
HELP